Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jean-Fabien Laurier"'
Autor:
Charles Dumontet, Jean-Fabien Laurier, Eva-Laure Matera, Stéphanie Herveau, Rouba Hage-Sleiman
Supplementary Figure 1 from Silencing of Tubulin Binding Cofactor C Modifies Microtubule Dynamics and Cell Cycle Distribution and Enhances Sensitivity to Gemcitabine in Breast Cancer Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::595a64553e4eb610bb10ce07a9de7091
https://doi.org/10.1158/1535-7163.22483715
https://doi.org/10.1158/1535-7163.22483715
Autor:
Charles Dumontet, Jean-Fabien Laurier, Eva-Laure Matera, Stéphanie Herveau, Rouba Hage-Sleiman
Supplementary Figure 3 from Silencing of Tubulin Binding Cofactor C Modifies Microtubule Dynamics and Cell Cycle Distribution and Enhances Sensitivity to Gemcitabine in Breast Cancer Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a511711a7deb1a333ece16b7746c034
https://doi.org/10.1158/1535-7163.22483709.v1
https://doi.org/10.1158/1535-7163.22483709.v1
Autor:
Charles Dumontet, Jean-Fabien Laurier, Eva-Laure Matera, Stéphanie Herveau, Rouba Hage-Sleiman
Supplementary Figure Legend for Supplementary Figure 1 from Silencing of Tubulin Binding Cofactor C Modifies Microtubule Dynamics and Cell Cycle Distribution and Enhances Sensitivity to Gemcitabine in Breast Cancer Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1598546954252957a4374eb4171b5c8a
https://doi.org/10.1158/1535-7163.22483706.v1
https://doi.org/10.1158/1535-7163.22483706.v1
Autor:
Charles Dumontet, Jean-Fabien Laurier, Eva-Laure Matera, Stéphanie Herveau, Rouba Hage-Sleiman
Supplementary Figure 2 from Silencing of Tubulin Binding Cofactor C Modifies Microtubule Dynamics and Cell Cycle Distribution and Enhances Sensitivity to Gemcitabine in Breast Cancer Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::586d1ebd46e02999dbe45a9fb4f1d7ca
https://doi.org/10.1158/1535-7163.22483712
https://doi.org/10.1158/1535-7163.22483712
Autor:
Charles Dumontet, Jean-Fabien Laurier, Eva-Laure Matera, Stéphanie Herveau, Rouba Hage-Sleiman
Tubulin binding cofactor C (TBCC) is essential for the proper folding of α- and β-tubulins into microtubule polymerizable heterodimers. Because microtubules are considered major targets in the treatment of breast cancer, we investigated the influen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01a86f4f0b187f17b6516a18a6896b39
https://doi.org/10.1158/1535-7163.c.6531215
https://doi.org/10.1158/1535-7163.c.6531215
Publikováno v:
Comptes Rendus Biologies. 325:393-400
Cell proliferation is a fundamental process involved in growth, development and oncogenesis. Monitoring and quantification of proliferation are essential to analyse the behaviour of cells drug-treated or not. Flow cytometry assessment of cell prolife
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::796d568a40b3cc63043252ff2b068777
https://doi.org/10.1016/s1631-0691(02)01440-3
https://doi.org/10.1016/s1631-0691(02)01440-3
Autor:
Eva-Laure Matera, Jean-Fabien Laurier, Rouba Hage-Sleiman, Charles Dumontet, Stéphanie Herveau
Publikováno v:
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics, American Association for Cancer Research, 2011, 10 (2), pp.303-12. ⟨10.1158/1535-7163.MCT-10-0568⟩
Molecular Cancer Therapeutics, American Association for Cancer Research, 2011, 10 (2), pp.303-12. 〈10.1158/1535-7163.MCT-10-0568〉
Molecular Cancer Therapeutics, American Association for Cancer Research, 2011, 10 (2), pp.303-12. ⟨10.1158/1535-7163.MCT-10-0568⟩
Molecular Cancer Therapeutics, American Association for Cancer Research, 2011, 10 (2), pp.303-12. 〈10.1158/1535-7163.MCT-10-0568〉
Tubulin binding cofactor C (TBCC) is essential for the proper folding of α- and β-tubulins into microtubule polymerizable heterodimers. Because microtubules are considered major targets in the treatment of breast cancer, we investigated the influen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7d7ea5c422c8d1b55b36d5066caf67c
https://hal.archives-ouvertes.fr/hal-00828515
https://hal.archives-ouvertes.fr/hal-00828515
Autor:
Rouba Hage-Sleiman, Charles Dumontet, Stéphanie Herveau, Jean-Fabien Laurier, Eva-Laure Matera
Publikováno v:
BMC Cancer
BMC Cancer, BioMed Central, 2010, 10 (1), pp.135. ⟨10.1186/1471-2407-10-135⟩
BMC Cancer, Vol 10, Iss 1, p 135 (2010)
BMC Cancer, BioMed Central, 2010, 10 (1), pp.135. ⟨10.1186/1471-2407-10-135⟩
BMC Cancer, Vol 10, Iss 1, p 135 (2010)
Background Microtubules are considered major therapeutic targets in patients with breast cancer. In spite of their essential role in biological functions including cell motility, cell division and intracellular transport, microtubules have not yet be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c80d1788c0cddfa2875927737428582
https://doi.org/10.1186/1471-2407-10-135
https://doi.org/10.1186/1471-2407-10-135
Autor:
Eva-Laure Matera, Charles Dumontet, Jean-Fabien Laurier, Stéphanie Herveau, Hage-Sleiman Rouba
Publikováno v:
Bulletin du Cancer. 97:S79-S80
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9313219a158e1c9e6104a40dcb2ec444
https://doi.org/10.1016/s0007-4551(15)31191-7
https://doi.org/10.1016/s0007-4551(15)31191-7